PressJuly 16, 2024 Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss
PressJuly 16, 2024 SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
Health & ScienceJuly 16, 2024 Braxia Scientific Corp. Delays Financial Report Amid Management Changes
PressJuly 12, 2024 Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
PressJuly 10, 2024 Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)
PressJuly 9, 2024 Red Light Holland CTIO to Unveil Groundbreaking iMicroapp Research Findings to Prestigious Drug Science Consortium
PressJuly 8, 2024 Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
PressJuly 8, 2024 Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
PressJuly 8, 2024 Clearmind Medicine Inc. Announces Advancement in its Proprietary MEAI- Based Binge Behaviors Treatment
PressJuly 3, 2024 Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Health & ScienceJuly 2, 2024 Analysis Reveals the Most Significant Improvements From Psychedelic Use Apply To Single Individuals
Health & ScienceJuly 2, 2024 Lykos Therapeutics Responds to ICER’s Critique of MDMA Assisted Psychotherapy for PTSD
